Coagulación intravascular diseminada fulminante en una paciente con leucemia promielocítica aguda

Revista Cubana de Medicina

Volumn 41, Issue 5, 2002, Pages 303-307

  Martínez López, Ivette ^a,b   Jimenez Armada, Jorge ^a   Ballmajó Real, Martha ^a   Sánchez García, Reynaldo William ^a   Solano Rolando, Manuel ^a  

^a Hospital Clinicoquirurgico Salvador Allende   (Cuba)

^b NONE   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 52649101987     PISSN: 00347523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bick Rlav. Disseminated intravascular coagulation and related syndromes. A clinical review. Semin Thromb Hemost 1995;14:299.
2. Bick Rlav. Disseminated intravascular coagulation and related syndromes. En: Bick RL, ed: Disorders of Hemostasis and Thrombosis: principles and clinical practice, New York, THIEME, 1985, p.157.
3. Baker WF. Clinical aspects of disseminated intravascular coagulation: A clinician's point of view. Semin Thromb Hemost 1989; 15: 1.
4. Bick RL. Disseminated intravascular coagulation. Objective criteria for clinical and laboratory diagnosis and assessment of therapeutic response. Clin Appl Thromb Hemost 1995;1(1):3-23.
5. Handing Robert J. Disorders of coagulation and thrombosis. En: Harrison's. Principles of internal medicine, 14th ed. Ed. Anthony S Fanci, DNLM Intern Med RC 46, No. 333, 1998. WB 115 #322.
6. Lococo F, Avvisati G, Diverio D, Petti MC, Alcalay M, Pandolfi PP, et al. Molecular evaluation of response to all-trans retinoic acid therapy in patients with hypergranular acute promyelocytic leukaemia. Blood 1995;77:1657.
7. Larson RA, Kondo K, Vardiman JW, Butter AE, Goloma AM, Rowley JD. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukaemia. Am J Med 1984;76:827-41.
8. Giuseppe Pelicci's, Pier???. Molecular Therapy for acute promyelocitic Leukemia. Semin Cell Develop Biol 1999;10:215-25.
9. Grimwade D, Walker H, Oliver F, Wheathey K, Harrison CH, Harrison G, et al. The importance of diagnostic cytogenetics on outcome in AML, analysis of 1,612 patients entered into MRC AML 10 trial. Blood 1998;92(7):2322-33.
10. Krzysztof Mrozek MD, PhD, Kristiina Heinonen MS, Clara D. Bloomfield MD. Clinical importance of cytogenetics in acute myeloid leukaemia. Bailliere's Best Pract Res Clin Haematol 2001;14:1.
11. Stanem PÑ. Hypergranular acute promyelocytic leukaemia with intravascular coagulation. Scand J Haematol 1989;2:249.
12. Swirsky DM, Richards GJ. Laboratory diagnosis of acute myeloid leukaemia. Bailliere's Best Pract Res Clin Haemat 2001;14:1.
13. Store RM, Mayer RJ. Acute myeloid leukemia in adults. In Clinical Oncology, New York: Churchill Livingstone, 1995;1959-76.
14. Fepauy P, Chorienue C, Decos L. Treatment of acute promyelocytic leukaemia. Bailliere's Best Pract Res Clin Haematol 2001;14:1.
15. Douer D, Santillana SS, Adamson PC. Efficacy of intravenous liposomal all-trans-retinoic acid in the treatment of acute promyelocytic leukaemia. Blood 2000;(suppl 1): Abstract 3123.
16. Stone RM. ALL, APL, and MDS. 42nd Annual Meeting of the American Society of Hematology. Hematology-Oncology Conference Summaries-© 2000 Medscape, Inc.
17. Soignet SL, Frankel S, Tallman M, Dover D, Tallman Ms, Kantorgicn H, et al. United States multicenter study of arsenic trioxide (ATO) in relapsed acute promyelocytic leukemia. J Clin Oncol 2001;19(18):3852-60.
18. Shen YL, Zhu Q, Cai X, Jia PM, Yu Y, Zhou L, et al. Arsenic trioxide induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Leukemia 2000;14(2):262-70.
19. Almagro Vázquez Delfina, Milanes MT, Díaz Concepción A, González García A, Espinosa Martínez E, et al. Trastornos de la hemostasia en la leucemia promielocítica aguda. Rev Cubana Hematol Inmunol Hemoter 1995;11(1):11-17.
20. Goasguen J, Bennett JM. The acute myeloid leukaemias morphology and cytochemistry in Hematology. Clinical and laboratory practice. St. Louis: Mosby-Year Book; 1993:1195-1216.
21. Degos L, Dombret H, Chomienne C, Darnel MT, Miclea JM, Chastang C, et al. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukaemia. Blood 1995;85:2643-53.